The MDIM project : Development of immuno-modulators derived from clinical gut microbiota strains The MDIM project (for Microbiota derived Immuno-Modulators) aims to establish a biotechnology company focused on the discovery and development of novel immunomodulatory therapeutics derived from gut microbiota strains isolated from exceptionally healthy individuals over 90 years of age. The founding hypothesis is that […]